CS Medica A/S (NGM:CSMED)
Sweden
· Delayed Price · Currency is SEK 1.013
-0.066 (-6.13%)
Inactive · Last trade price
on Jan 9, 2025
CS Medica Balance Sheet
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 |
| Cash & Equivalents | 0.02 | -0.42 | 2.93 | 10 | 0.3 | Upgrade
|
| Cash & Short-Term Investments | 0.02 | -0.42 | 2.93 | 10 | 0.3 | Upgrade
|
| Cash Growth | - | - | -70.65% | 3267.00% | - | Upgrade
|
| Accounts Receivable | 3.86 | 2.45 | 6.49 | 1.64 | 0.05 | Upgrade
|
| Other Receivables | 0.23 | -0.09 | 0 | 1.46 | 0.07 | Upgrade
|
| Receivables | 4.08 | 2.37 | 6.49 | 3.1 | 0.12 | Upgrade
|
| Inventory | 0.96 | 2.71 | 1.35 | 1.23 | 1.12 | Upgrade
|
| Other Current Assets | 0 | - | 0 | - | - | Upgrade
|
| Total Current Assets | 5.07 | 4.66 | 10.78 | 14.33 | 1.98 | Upgrade
|
| Other Intangible Assets | 14.87 | 13.63 | 13.51 | 12.78 | 3.45 | Upgrade
|
| Long-Term Deferred Tax Assets | 12.28 | 7.46 | 3.51 | 0.23 | - | Upgrade
|
| Other Long-Term Assets | 4.17 | 0.11 | 0.11 | 0.08 | - | Upgrade
|
| Total Assets | 36.38 | 25.86 | 27.91 | 27.41 | 5.44 | Upgrade
|
| Accounts Payable | 8.9 | 5.11 | 1.19 | 0.5 | 0.49 | Upgrade
|
| Short-Term Debt | 0.81 | - | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 3.75 | 0.19 | 0.45 | 0.4 | - | Upgrade
|
| Other Current Liabilities | 3.47 | 1.55 | 0.58 | 0.71 | 0.38 | Upgrade
|
| Total Current Liabilities | 16.93 | 6.85 | 2.22 | 1.62 | 0.87 | Upgrade
|
| Long-Term Debt | 8.63 | 8.59 | 0.59 | 1.31 | 3.23 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | 0.76 | Upgrade
|
| Other Long-Term Liabilities | 4.8 | - | 0.16 | 0.33 | 0.49 | Upgrade
|
| Total Liabilities | 30.36 | 15.44 | 2.98 | 3.26 | 5.35 | Upgrade
|
| Common Stock | 1.11 | 0.8 | 0.8 | 0.71 | 0.08 | Upgrade
|
| Retained Earnings | -4.54 | 1.69 | 16.69 | 16.29 | -2.68 | Upgrade
|
| Comprehensive Income & Other | 9.45 | 7.92 | 7.44 | 7.15 | 2.69 | Upgrade
|
| Shareholders' Equity | 6.02 | 10.41 | 24.93 | 24.15 | 0.09 | Upgrade
|
| Total Liabilities & Equity | 36.38 | 25.86 | 27.91 | 27.41 | 5.44 | Upgrade
|
| Total Debt | 13.19 | 8.78 | 1.04 | 1.72 | 3.23 | Upgrade
|
| Net Cash (Debt) | -13.17 | -9.19 | 1.89 | 8.28 | -2.93 | Upgrade
|
| Net Cash Growth | - | - | -77.16% | - | - | Upgrade
|
| Net Cash Per Share | -0.77 | -0.75 | 0.16 | 1.52 | - | Upgrade
|
| Filing Date Shares Outstanding | 17.13 | 12.32 | 12.32 | 10.9 | - | Upgrade
|
| Total Common Shares Outstanding | 17.13 | 12.32 | 12.32 | 10.9 | - | Upgrade
|
| Working Capital | -11.87 | -2.19 | 8.56 | 12.71 | 1.12 | Upgrade
|
| Book Value Per Share | 0.35 | 0.85 | 2.02 | 2.21 | - | Upgrade
|
| Tangible Book Value | -8.85 | -3.21 | 11.41 | 11.37 | -3.36 | Upgrade
|
| Tangible Book Value Per Share | -0.52 | -0.26 | 0.93 | 1.04 | - | Upgrade
|
| Order Backlog | 49 | 14.5 | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.